Clinical trials
Phase 4 Ischemic Stroke trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 9 |
| 2025 | 4 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 18 |
| Recruiting | 13 |
| Not yet recruiting | 10 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| General Hospital of Shenyang Military Region | 5 |
| Xuanwu Hospital, Beijing | 5 |
| Sichuan Provincial People's Hospital | 4 |
| China Academy of Chinese Medical Sciences | 3 |
| Dongzhimen Hospital, Beijing | 3 |
| Xijing Hospital | 3 |
| Beijing Tiantan Hospital | 2 |
| Guangzhou University of Traditional Chinese Medicine | 2 |
| Jiangsu Kanion Pharmaceutical Co., Ltd | 2 |
| Jinling Hospital, China | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 65 |
| Stroke | 9 |
| Brain Ischemia | 2 |
| Hereditary Sensory and Autonomic Neuropathies | 2 |
| Hypertension | 2 |
| Intracranial Arteriosclerosis | 2 |
| Atherosclerosis | 1 |
| Brain Death | 1 |
| Brain Edema | 1 |
| Brain Infarction | 1 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.